Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has so far infected 762 million people with over 6.9 million deaths worldwide. Broad-spectrum viral inhibitors that block the initial stages of infection by reducing virus binding and proliferation, thereby reducing disease severities, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Subhadra, Bobban, Agrawal, Ragini, Pal, Virender Kumar, Chenine, Agnes-Laurence, Mattathil, Jeffy George, Singh, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305169/
https://www.ncbi.nlm.nih.gov/pubmed/37376598
http://dx.doi.org/10.3390/v15061299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305169/
https://www.ncbi.nlm.nih.gov/pubmed/37376598
http://dx.doi.org/10.3390/v15061299

Ejemplares similares